Sustained measurable residual disease negativity or guaranteed survival time in multiple myeloma?
British Journal of Haematology · 08.11.2026
DOI: 10.1111/bjh.70949 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Haematology, online erschienen am 08.11.2026. Verfasst von Xin Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China. Die Arbeit nennt 4 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Shandong University Horizontal Research Projects.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Hematology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China.
ORCID-Profile: Xin Zhou
Förderung
- Natural Science Foundation of Shandong Province
- Shandong University Horizontal Research Projects
Zitieren
APA
Zhou, X., & Shan, N. (2026). Sustained measurable residual disease negativity or guaranteed survival time in multiple myeloma?. British Journal of Haematology. https://doi.org/10.1111/bjh.70949
Vancouver
Zhou X, Shan N. Sustained measurable residual disease negativity or guaranteed survival time in multiple myeloma?. British Journal of Haematology. 2026. doi:10.1111/bjh.70949
BibTeX
@article{Zhou2026,
author = {Zhou, Xin and Shan, Ningning},
title = {Sustained measurable residual disease negativity or guaranteed survival time in multiple myeloma?},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70949}
}
EUVIMED